News & Events
JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"
-
2021-02-26
JOINN was Successfully Listed on the Hong Kong Stock Exchange
... -
2020-04-03
JOINN’s Clinical Team Participated in the Clinical Trials of Highlypathogenic Coronavirus N Protein
... -
2020-03-18
A Milestone has been Reached in the Development of COVID-19 Vaccines
... -
2020-02-16
JOINN's Analysis and Clinical Team Went to Wuhan to help with Novel Coronavirus New Drug R&D
... -
2019-12-11
JOINN Laboratories and Biomedical Research Models Inc. (“Biomere”) Finalize Deal to Merge
... -
2019-09-02
Fully Obtained the Medical Device Evaluation Qualification-- JOINN (Suzhou) Passed the CNAS Verification
... -
2019-04-01
JOINN(Wuzhou) Held Construction Ceremony
... -
2019-03-30
JOINN Southwest Center has been established in Chongqing
...
